Meyer Handelman Co. Sells 7,346 Shares of CVS Health Corporation $CVS

Meyer Handelman Co. lessened its holdings in shares of CVS Health Corporation (NYSE:CVS) by 13.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 48,072 shares of the pharmacy operator’s stock after selling 7,346 shares during the period. Meyer Handelman Co.’s holdings in CVS Health were worth $3,815,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in CVS. National Pension Service grew its position in CVS Health by 3.1% in the 3rd quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock worth $301,532,000 after purchasing an additional 119,189 shares during the last quarter. Kingsview Wealth Management LLC lifted its stake in shares of CVS Health by 316.2% in the third quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator’s stock valued at $7,873,000 after buying an additional 79,340 shares during the period. AE Wealth Management LLC lifted its stake in shares of CVS Health by 6.2% in the third quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock valued at $19,391,000 after buying an additional 14,983 shares during the period. Mirae Asset Global Investments Co. Ltd. grew its position in CVS Health by 11.2% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator’s stock worth $16,971,000 after buying an additional 22,653 shares in the last quarter. Finally, Alpha Omega Wealth Management LLC increased its stake in CVS Health by 12.3% during the third quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock valued at $11,301,000 after acquiring an additional 16,418 shares during the period. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on CVS shares. Bank of America reduced their price objective on CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a research report on Tuesday, January 27th. Wolfe Research lowered their price objective on CVS Health from $100.00 to $97.00 and set an “outperform” rating on the stock in a research report on Monday, March 2nd. Robert W. Baird upped their target price on CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. JPMorgan Chase & Co. lifted their price target on shares of CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 17th. Finally, Royal Bank Of Canada reissued an “outperform” rating on shares of CVS Health in a report on Thursday, December 4th. Twenty investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.95.

CVS Health Trading Up 2.5%

Shares of CVS opened at $71.86 on Wednesday. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. The stock has a market cap of $91.42 billion, a PE ratio of 52.07, a PEG ratio of 0.73 and a beta of 0.49. CVS Health Corporation has a 1 year low of $58.35 and a 1 year high of $85.15. The stock has a 50 day simple moving average of $76.29 and a 200-day simple moving average of $77.74.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. During the same quarter in the previous year, the firm earned $1.19 EPS. CVS Health’s quarterly revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, sell-side analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, April 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.7%. CVS Health’s dividend payout ratio is presently 192.75%.

Trending Headlines about CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS is expanding its retail footprint in 2026 — management plans roughly 60 store openings this year (including nearly 20 smaller pharmacy?only or “apothecary” sites) as it pivots from prior net closures; the company opened its first pharmacy?only location in Chicago. CVS Pharmacy® celebrates opening of first pharmacy-only location in Chicago
• Positive Sentiment: Market reaction to the store strategy: coverage highlights (Bloomberg/WSJ) that CVS will open more stores than it closes in 2026 — signals management sees profitable opportunities in community pharmacy. CVS to Grow Store Footprint This Year With 60 New Locations
• Positive Sentiment: Unusually heavy call?option activity: traders purchased ~30,223 calls (about +52% vs. average), indicating speculative bullish positioning that can amplify intraday upside.
• Neutral Sentiment: Piper Sandler trimmed its price target from $101 to $99 but kept an Overweight rating — a modest PT cut that still implies sizable upside vs. the current level, so the note is supportive but slightly cautious. Benzinga
• Neutral Sentiment: Analyst/education pieces (Zacks/Yahoo) are flagging CVS as a company to watch with earnings?beat potential using tools like Earnings ESP — these stories can attract short?term interest but are speculative ahead of actual results. CVS Health (CVS) Increases Yet Falls Behind Market: What Investors Need to Know
• Negative Sentiment: Regulatory/legal risk: CVS reached a proposed FTC settlement over insulin pricing — the final terms and any financial penalties or behavioral remedies remain a potential headwind. CVS Health (CVS) Reaches Proposed FTC Settlement on Insulin Pricing

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.